Records containing: Melanoma (Skin)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2013-05-30A Multicenter Phase II Trial of MGI-114 in Patients With Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-30A Phase I Study Using Direct Combination DNA Injections for the Immunotherapy of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-30Genetic Epidemiologic Studies of Melanoma in Iceland
-
CLINICAL_TRIALS study record update · 2013-05-17A Phase II Study of SB-715992 (NSC 727990) in Previously Untreated Patients With Metastatic or Recurrent Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-15A Randomized Phase II Study of Fixed Dose Ipilimumab (MDX-010) 10 mg/kg Given Alone or in Combination With Two gp100 Peptides Emulsified With Montanide ISA-51 VG for Previously Treated HLA-A * 0201 Positive Subjects With Stage IV Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2013-05-13Phase III Randomized Study of Four Weeks High Dose IFN-2b in StageT3-T4 or N1 (Microscopic) Melanoma
-
CLINICAL_TRIALS study record update · 2013-05-01A Phase I, Open-Label, Maximum Tolerated Single-Cycle and Four-Cycle Dose-Finding Study to Evaluation the Safety and Tolerability of 90Y-SMT 487 Administered by Intravenous Infusion to Subjects With Refractory Somatostatin-Receptor Positive Tumors
-
CLINICAL_TRIALS study record update · 2013-05-01Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-04-12A Phase I/II Trial of a Human Anti-Idiotypic Monoclonal Antibody Vaccine (4B5) Which Mimics the GD2 Antigen, in Patients With Melanoma
-
CLINICAL_TRIALS study record update · 2013-04-10High Dose Interleukin-2 (IL-2) Therapy In "Lymphodepleted Primed" Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-04-10Temozolomide Combined With Bevacizumab in Metastatic Melanoma. A Multicenter Phase II Trial
-
CLINICAL_TRIALS study record update · 2013-04-08Phase II Study of Pegylated Interferon and Thalidomide in Pretreated Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-04-05Immunotherapy for Malignant Melanoma - Phase II Trial of Autologous Cancer Antigen Specific Immunotherapy
-
CLINICAL_TRIALS study record update · 2013-04-04A Pilot Trial of Therapeutic Vaccination With a Modified gp100 Melanoma Peptide (gp100:209-217(210M)), Montanide ISA 51, and KLH With Reconstitution After Chemotherapy to Induce Lymphopenia in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-03-27Treatment of Patients With Metastatic Melanoma Using a Transplant of Autologous Lymphocytes Reactive With Tumor Following a Myeloablative Lymphocyte Depleting Regimen of Chemotherapy, Total Body Irradiation and Reconstitution With CD34+ Cells
-
CLINICAL_TRIALS study record update · 2013-03-26Treatment of Patients With Metastatic Malignant Melanoma With Chemobiotherapy With Temozolomide, GM-CSF, IL2, and Interferon Alfa-2b Phase II Trial
-
CLINICAL_TRIALS study record update · 2013-03-25A Phase I-II Trial of Antigen-Pulsed Autologous Dendritic Cells for Induction of Anti-Tumor Immunity in Patients Completing Lymphadenectomy for Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-03-21Phase I Trial of rhIL-12 and rHuIFN-a2b in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-03-12Injection of AJCC Stage IIB, IIC, III, and IV Melanoma Patients With Human and Mouse gp100 DNA: A Phase I Trial to Assess Safety and Immune Response
-
CLINICAL_TRIALS study record update · 2013-03-01A Pilot Study of the Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-28Phase I Trial of a Dendritic Cell Vaccine for Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-20PHASE I STUDY OF MONOCLONAL ANTIBODY FRAGMENT 131I MEL-14 F(AB')2 VIA SURGICALLY CREATED CYSTIC RESECTION CAVITY IN THE TREATMENT OF PATIENTS WITH PRIMARY OR METASTATIC MALIGNANT MELANOMA AND OTHER BRAIN TUMORS
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase II Trial of O6-Benzylguanine (NSC 637037) and BCNU (Carmustine) in Patients With Metatstatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase II, Pharmacologic and Biologic Study of Escalating Doses of Thalidomide (NSC #66847) Administered Orally Once a Day in Combination With a Fixed Dose of SU5416 (NSC #696819) in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2013-02-11A Phase I Trial of Intra Lesional RV-B7.1 Vaccine in the Treatment of Malignant Melanoma